- Home
- CRVO vs CHMI Comparison
CRVO vs CHMI Comparison
Compare CRVO & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRVO | CHMI |
|---|---|---|
| Founded | 2001 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.5M | 83.3M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | CRVO | CHMI |
|---|---|---|
| Price | $7.33 | $2.76 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $21.50 | $2.75 |
| AVG Volume (30 Days) | 57.6K | ★ 207.3K |
| Earning Date | 11-10-2025 | 03-05-2026 |
| Dividend Yield | N/A | ★ 14.81% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $6,159,786.00 | ★ $40,202,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $31.73 |
| P/E Ratio | ★ N/A | $144.11 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.92 | $2.17 |
| 52 Week High | $16.94 | $3.68 |
Technical Indicators
Market Signals| Indicator | CRVO | CHMI |
|---|---|---|
| Relative Strength Index (RSI) | 37.66 | 63.79 |
| Support Level | $6.90 | $2.55 |
| Resistance Level | $8.22 | $2.78 |
| Average True Range (ATR) | 0.51 | 0.08 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 14.10 | 98.31 |
Price Performance
Historical ComparisonAbout CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.